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The seventh killer cell immunoglobulin-like receptor (KIR) workshop was held at Tammsvik, Stockholm,
Sweden, in the summer of 2011. This intimate and isolated setting brought together approximately 100 inves-
tigators, from a range of scientific disciplines, who are all actively working on KIRs in humans or closely
related primate species.Introduction
After the discovery of natural killer (NK) cells in the early 1970s,
tumor immunologists turned to the mechanisms by which NK
cells distinguish healthy cells from diseased cells. Persistent
exploration led to appreciation that NK cells preferred targets
cells that are lacking, or ‘‘missing,’’ self-MHC class I (Ka¨rre
et al., 1986). Subsequent discovery of inhibitory MHC class I
receptors on mouse and human NK cells (Moretta et al., 2006)
gave an elegantly satisfying solution to the puzzle of the
‘‘missing-self’’ phenomenon. To everyone’s surprise, the mouse
Ly49 and human killer cell immunoglobulin-like receptors (KIRs)
that recognize MHC class I were seen to be products of conver-
gent evolution, forewarning the extraordinary diversity and
species specificity of these primate-specific NK cell receptors.
Recognizing the evolutionary chasm that separates mouse
Ly49 from human KIR served to stimulate intensive, cooperative
study of the human system for exploration of the biology and
clinical relevance of the KIRs and their interactions with HLA
class I.
In 2001, John Trowsdale held an informal gathering at
Emmanuel College Cambridge, UK, for the small but growing
number of workers in the field. Thus began the ‘‘KIR work-
shops’’ where, within a framework of short talks embracing all
participants, the latest and mostly unpublished data are vigor-
ously discussed. In the open atmosphere of these intimate
meetings, many key contributions to KIR biology have first
been reported, taking the research in diverse and complemen-
tary directions. These include evolution, population genetics,
reproduction, infection, and, of course, cancer. This summer,
the seventh KIR workshop was held at an isolated conference
center outside of Stockholm, Sweden (Figure 1). In reporting
here on the achievements of the workshop, we cover the latest
advances and review the state of the art in this rapid evolving
field of immunological research.
Evolution of KIRs
Comparison of KIR and MHC gene families in mammalian
species demonstrates their rapid evolution under forces of
natural selection and genetic drift (Parham, 2008). That struc-
turally unrelated KIR and Ly49 receptors with analogous MHCclass I binding function evolved independently highlights the
importance and plasticity of this function. Whereas mice, rats,
and horses express variable Ly49, cattle, monkeys, apes, and
humans express variable KIRs. Strong species specificity to
the evolution of KIR and Ly49 receptors probably reflects
distinctive and competing selections imposed on NK cells by
their contributions to immune defense and reproduction, func-
tions necessary for individuals, populations, and species to
survive.
From comparison of representative primate species, Laurent
Abi-Rached (Stanford, USA) proposed a model for the emer-
gence and diversification of KIR genes in primates. Whereas
simian primates (monkeys, apes, and humans) have diverse
KIRs, prosimian primates have a single nonfunctional KIR
gene. Thus, expansion of one ancestral KIR3DL to become
a diverse and rapidly evolving gene family occurred only in
simian primates.
The ligand-binding specificities of human (and ape) KIRs are
restricted to the A3/11, Bw4, C1, and C2 epitopes carried by
subsets of HLA-A, -B, and -C allotypes. Old World monkeys,
including rhesus macaques, have counterparts to HLA-A and
HLA-B but not to HLA-C, as described by Peter Parham
(Stanford, USA). Unexpectedly, nine rhesus macaque KIR3DL
bound strongly to human HLA-C, but only weakly to HLA-A,
and with intermediate strength to HLA-B. Emerging in hominoids
from an HLA-B like ancestor, HLA-C has evolved under natural
selection to become an inherently better KIR ligand than HLA-A
or -B. Whereas every HLA-C allotype is a KIR ligand, balancing
selection maintains only one-third of HLA-A and -B allotypes
as KIR ligands, whereas two-thirds are dedicated T cell receptor
ligands.
Continuing her analysis of KIR haplotype structure, Lisbeth
Guethlein (Stanford, USA) showed that structural variation in
orangutan and chimpanzee KIR haplotypes is restricted to the
centromeric region of the KIR locus. In contrast, human KIR
haplotypes uniquely display structural variation in both the
centromeric and telomeric regions. Different gene-content
motifs in the centromeric (Cen-A and Cen-B) and telomeric
(Tel-A and Tel-B) regions combine to form the group A and B
KIR haplotypes, which also are unique to humans.Immunity 35, November 23, 2011 ª2011 Elsevier Inc. 653
Figure 1. The Tammsvik Conference Site Just outside Stockholm
where the Seventh KIR Workshop Was Held
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That all human populations have both group A and B KIR
haplotypes points to them having important and complementary
functions. Although their relative frequencies vary, balancing
selection maintains the A and B KIR haplotypes even in small
geographically isolated populations such as the Yucpa Amerin-
dians (Parham, 2008).
HLA and KIR are functionally interacting gene families situated
on chromosomes 6 and 19, respectively. Because both are
exceptionally polymorphic, the combinatorial diversification of
their functional interaction is enormous. Paul Norman (Stanford,
USA) compared this potential in two distinctive African popula-
tions: the older, smaller Khoisan from southern Africa and the
younger, larger Ghanaian from West Africa. Despite different
demographic histories, they displayed similar functional poten-
tial. Individuals have at least 1, a mean of 8, and a maximum of
15 different HLA-KIR interactions. Although overall functional
diversity was similar, a striking difference was a unique and
dominant form of KIR2DL1 in the Khoisan that has C1 specificity
instead of the C2 specificity generally associated with this KIR.
The close head-to-tail organization of the KIR genes facili-
tates nonhomologous recombination with evolution of new KIR
haplotypes through gain and loss of genes. Developing new
technology that types for both presence and copy number of
KIR genes, James Traherne (Cambridge, UK) uncovered KIR
haplotypes displaying unique examples of gene expansion or
contraction, representing up to 4% of Caucasian KIR haplo-
types.
By sequencing coding regions for the 14 functional KIR
genes and determining their phase, Carolyn Hurley (Washing-
ton D.C., USA) defined allele-level KIR haplotypes in 76
European Americans, with gene content frequencies similar to
those reported for other Caucasian panels. Three factors
contribute to haplotype diversity: random association of centro-
meric and telomeric gene-content motifs, formation of new
gene-content motifs, and mutation for generating new alleles
of the individual KIR genes. Cynthia Vierra-Green (Minneapolis,
USA) similarly described 1012 KIR haplotypes in a panel of 506
Caucasians. These haplotypes involved association of nine
centromeric and eight telomeric motifs, with three centromeric654 Immunity 35, November 23, 2011 ª2011 Elsevier Inc.(Cen-A1, -B1, and -B2) and two telomeric (Tel-A1 and -B1)
motifs accounting for 972 (96%) of them. Such high-resolution
KIR analyses are necessary for achieving precise definition of
KIR variation in human populations and accurate assessment
of disease and other clinical associations.
Regulation of KIR Repertoires
Transcription of the KIR locus occurs late in NK cell develop-
ment. KIR2DL4, the central framework gene, is transcribed first,
and the other KIR genes subsequently transcribed. As the result
of a complex and only partially understood process, each KIR is
expressed by a subset of NK cells and individual NK cells
express different combinations of KIR. The variegated patterns
of KIR expression are stabilized by methylation of the nonex-
pressed genes and produce a diverse NK cell repertoire.
KIR genes can have two or more promoters, which produce
competing sense and antisense transcripts that determine the
frequency with which each KIR is expressed in the NK cell pop-
ulation.
In progenitor but not mature NK cells, Frank Cichocki
(Minneapolis, USA) identified antisense transcripts originating
from the second intron of the KIR2DL1, KIR2DS1, and
KIR3DL1/S1 genes. Induction of this antisense from the
KIR2DL1 gene shuts of production of the KIR2DL1 protein.
Such results suggest intron 2 antisense transcripts serve to
silence KIR genes in immature cells. Furthermore, Lutz Walter
(Go¨ttingen, Germany) and collaborators identified a potential
binding site for micro-RNA miR-24 33–55 base pairs upstream
of the canonical AUG start codon of KIR genes. Knockdown
of endogenous miR-24 by an anti-miR-24 construct induced
transcription of KIR genes in HeLa and 293 cell lines, pointing
to a role for this miR in regulation of KIR expression.
Martin Ivarsson (Stockholm, Sweden), showed that KIR
expression was detectable on fetal NK cells by the second
trimester, particularly in the lung. The unique exposure of fetal
lung NK cells to amniotic fluid raises the intriguing possibility
that KIR-expressing NK cells in the fetal lung provide defense
against infection arriving in the amniotic fluid.
Multi-parameter flow cytometry analyses of human NK cell
receptor repertoires suggests all receptor combinations are
allowed, implying an absence of negative selection that deletes
NK cells with receptor combinations that are harmful or useless
(Andersson et al., 2010). Accumulation of NK cells expressing
self-specific KIRs might arise from viral imprinting during
childhood. Indeed, CMV seropositive individuals exposed to
hantavirus infection have expanded populations of highly
differentiated NKG2C+ NK cells that preferentially express
self-reactive KIRs (Bjo¨rkstro¨m et al., 2011). Similarly, Vivien
Beziat (Paris, France) discussed how CMV drives expansion of
similar NK cell populations in patients chronically infected with
HCV or HBV.
After reviewing NK cell repertoire development in humans
and mice, Petter Ho¨glund (Stockholm, Sweden) concluded that
the mouse Ly49 and human KIR repertoires are remarkably
similar in their basic compositions. However, interactions
with self-MHC class I caused greater repertoire skewing in the
mouse.
CD8+ T cells acquire KIRs during maturation from naive to
fully differentiated effector cells. Their KIR repertoires are
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reacting with self-MHC class I (Niklas Bjo¨rkstro¨m: Stockholm,
Sweden). Although NK cells are commonly assumed to cause
the clinical effects correlating with epistatic interactions between
KIR and HLA, this hypothesis remains largely untested. Conse-
quently, contribution from KIR-expressing CD8 T cells cannot
be dismissed.
KIR and Reproduction
Maternal uterine NK (uNK) cells function in reproduction by
interacting with fetal trophoblasts that invade the uterus and
convert small spiral arteries into voluminous channels that will
nourish the growing fetus. Inadequate trophoblast invasion
causes several common disorders of pregnancy: recurrent
miscarriage, preeclampsia, and fetal growth restriction (Moffett
and Loke, 2006). Emerging evidence points to a balanced
trophoblast-NK cell interaction being crucial for achieving
optimal depth of invasion. Modulating these cellular interactions
are interactions uNK cell KIRs and HLA class I ligands of the
trophoblast.
Ashley Moffett (Cambridge, UK) emphasized how tropho-
blasts express maternal and parental HLA-C, but no HLA-A or
HLA-B. Pregnancies during which the fetus expresses the C2
epitope, particularly paternal C2, and the mother is homozygous
for A KIR haplotypes are at risk for pregnancy disorder. Such
observations implicate overly inhibitory interactions between
maternal KIR2DL1 (an inhibitory receptor) and fetal C2 in
disease. Consistent with this mechanism, the combination of
fetal C2 and a maternal KIR B haplotype, which has KIR2DS1
encoding the activating C2 receptor, is protective (Hiby et al.,
2010). Extending the resolution of this analysis to the allele level,
Olympe Chazara (Cambridge, UK) found that homozygosity for
KIR2DL1*003, the commonest KIR2DL1 allele, appears to be
most strongly associated with pregnancy disorder.
Abnormally high or low birth weight associates with perinatal
mortality, as well as maternal morbidity and mortality. Whereas
implantation disorders correlate with fetal C2 and maternal KIR
A haplotypes, Susan Hiby (Cambridge UK) found that high birth
weight associates with the combination of fetal C2 and the
telomeric region (Tel-B) of maternal KIR B haplotypes. Hence,
interaction of fetal C2 with KIR2DS1, encoded in Tel-B, could
cause overactivation of uNK leading to excessive invasion of
spiral arteries and dangerously high birth weights. Overall, the
spectrum of disease associations in pregnancy emphasizes
the importance of a balanced uNK cell response during tropho-
blast invasion.
Pippa Kennedy (Cambridge, UK) compared telomeric KIR
gene expression in blood and uterine NK cells from the same
donor. Whereas KIR2DL1, KIR2DS1, and KIR2DS4 were ex-
pressed at high frequencies by uNK, KIR2DL5 was undetectable
on uNK, although clearly present on blood NK cells. Inverse
correlation of nonfunctional KIR2DS4 del with successful preg-
nancy suggests that functional KIR2DS4, a Tel-A gene encoding
an activating receptor that recognizes some HLA-C, along with
KIR2DS1 in the Tel-B region, contribute to reproductive success.
Supporting this theory is the fact that a high frequency of uNK
cells expresses activating KIRs that recognize HLA-C.
Francesco Colucci (Cambridge, UK) described how mice, like
humans, exhibit invasive placentation (Colucci et al., 2011).Furthermore, mouse trophoblast expresses paternal MHC class
I that influences the uterine NK cell Ly49 receptor repertoire and
decidual vascularization during implantation.
KIR and Infection
Defense against viruses is a major function of NK cells. Homo-
zygosity for KIR2DL3 and HLA-C1 correlates with resolution of
acute hepatitis C virus (HCV) infection (Khakoo et al., 2004).
Building upon this foundation, Clair Gardiner (Dublin, Ireland)
examined a unique cohort of >500 women infected with the
same strain of HCV, a contaminant in the anti-D immunoglobulin
they received as prophylactic treatment for preventing hemo-
lytic disease of the newborn. Besides confirming the protective
role of the KIR2DL3 and C1 combination, KIR2DS3 and C2 had
the detrimental effect of favoring chronic infection. Becca
Asquith (London, UK) reported that KIR2DL2 increased the
protective role of HLA-B57 and HLA-C8 in HCV and HLTV-1
and the detrimental role of HLA-B54 in HTLV-1, suggesting
that KIR2DL2 expression enhances virus-specific CD8+ T cells.
Study of KIRs in human immunodeficiency virus (HIV) infection
has mainly focused on viral control and progression to AIDS
(Bashirova et al., 2011). Now investigating HIV transmission,
Elizabeth Trachtenberg (Oakland, USA) reported that activating
KIR genes, including KIR2DS1, KIR2DS4, and KIR2DS5, corre-
lated with protection against HIV transmission. In contrast,
KIR3DL1 and KIR3DS1, which associate with slower progres-
sion to AIDS, were not protective. Thus, different KIRs may
contribute to establishment and progress of infection.
Although it is well established that macaques have diverse
KIRs, knowledge of their interactions with MHC class I is only
now emerging. Using pig-tailed macaques, Bernard Lafont
(Bethesda, USA) demonstrated functional interactions between
KIR and MHC class I allotypes that inhibit NK cells. Meike
Hermes (Go¨ttingen, Germany) studied KIR expression in
rhesus macaque NK cells and T cells by using a new panel of
anti-macaque KIR antibodies. Investigation of SIV-infected
rhesus macaques by Christina Albrecht (Go¨ttingen, Germany)
showed that rhesus macaque KIR3DL02 is associated with low
viral load, whereas KIR3DL10*002, KIR3DS05, and KIR3DSw08
are associated with high viral load. Together, these findings
should facilitate more incisive dissection of the role of KIRs
and NK cells in SIV infection: the major experimental model for
human HIV infection.
KIR and Therapeutic Interventions
When applying allogeneic hematopoetic stem cell transplanta-
tion (HSCT) as therapy for acute myeloid leukemia (AML), the
gold standard is for the donor and recipient to be HLA identical.
When this cannot be achieved, transplantation is performed
across a range of HLA-A, -B, and -C mismatches. With certain
types of mismatch, NK cells of donor origin respond to
‘‘missing-self’’ in the recipient. By attacking residual leukemia
cells, these alloraective NK cells can reduce the incidence of
relapse and improve patient survival. These effects, however,
vary with transplant center and transplant protocol, as well as
the HLA mismatch. Regardless of HLA type, transplants from
donors with B KIR haplotypes reduce relapse and improve
survival after HSCT, with the major effect coming from Cen-B
haplotype (Cooley et al., 2010). This retrospective analysis isImmunity 35, November 23, 2011 ª2011 Elsevier Inc. 655
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will be considered when selecting transplant donors.
The variability in clinical outcomes presents amajor challenge,
one that demands knowledge and understanding of the vari-
ables contributing to beneficial NK cell alloreactivity. In partic-
ular, the processes involved in the reconstitution, maturation,
and education of NK cell populations after HSCT remain largely
unknown. During NK cell education, interactions between
KIR and self-MHC class I determines how mature NK cells can
respond to ‘‘missing-self’’-MHC class I (Anfossi et al., 2006;
Ho¨glund and Brodin, 2010). Whereas some studies, including
results presented by Paul Fisch (Freiburg, Germany), report
breaking of NK cell tolerance during the early posttransplanta-
tion period (Hsu et al., 2005), others find that functional NK cells
depend upon continuing education by donor HLA class I, after
transplant (Haas et al., 2011). In this context, Sarah Cooley (Min-
neapolis, USA) examined the dynamics of NK cell responses
after adoptive transfer of haploidentical NK and described how
uneducated, functionally immature donor NK cells gained func-
tion after interactions with recipient HLA class I. By contrast,
when educated NK cells were transferred into a patient with no
HLA class I ligands, they retained function, a possible conse-
quence of the patients having received subcutaneous IL-2.
Clinical trials performed by Jeff Miller, Sarah Cooley, and
collaborators (Minneapolis, USA) showed how adoptive transfer
of haploidentical NK cells induced remission for 31% of patients
with refractory AML, an effect correlating with expansion of
donor NK cells. They also reported exciting, but preliminary,
results from a trial combining adoptive NK cell therapy with a
recombinant DNA-derived cytotoxic protein composed of diph-
theria toxin and human interleukin-2a (Ontak, denileukin diftitox).
With this regimen, in which regulatory T cells were depleted,
a large majority of patients, with previously refractory AML,
cleared disease and proceeded to allogeneic HSCT.
Last, but not least, Ariane Thielens (Marseille, France) de-
scribed the development of a potentially therapeutic monoclonal
human IgG4 (IPH2101) with broad specificity for KIR2DL1,
KIR2DL2, and KIR2DL3, the inhibitory HLA-C-specific KIRs.
Future strategies may combine such anti-KIR antibodies with
adoptive transfer of highly activated NK cells to further improve
the efficacy of treatment.
Concluding Remarks
Inescapable from this KIR workshop is the fact that variable
KIR-HLA interactions are crucial modulators of lymphocyte
function in human immunity, reproduction, and resistance to
cancer. In the decade since the first KIR workshop, much
knowledge of KIRs’ place in NK cell biology has been attained.
Less developed is understanding of the cellular and molecular
mechanisms that underlie the immunogenetic correlations of
KIR-HLA with disease and its treatment. An obvious limiting
factor is that epidemiological and population studies are usually
performed at the low KIR gene-content resolution achieved by
commercial KIR typing kits. High-resolution allele-level analysis
is essential at this stage in the study of KIRs, and several exam-
ples of it were presented at the workshop. By defining precisely
KIR variation in human populations, high-resolution analysis
will inform the simplifications necessary to translate KIR typing
into clinical analysis and application. Without high-resolution656 Immunity 35, November 23, 2011 ª2011 Elsevier Inc.data, any such simplifications will only be guesswork. Further-
more, because both KIR and HLA class I are highly variable,
new tools are needed to study the range of their molecular
interaction and the effects it has in diversifying human NK cell
receptor repertoires and their responses to disease and preg-
nancy. Adding to the challenge is the underinvestigated contri-
bution of the variable peptides that are bound to HLA class I
and that are known to contact KIRs.
In his masterly ‘‘wrapping up’’ of the 7th KIR workshop, Klas
Ka¨rre (Stockholm, Sweden), alluded to the fact that KIR studies
have provided new insights into the history of modern humans,
including their origin and adaptation to environmental stress,
such as epidemic infections. From a medical perspective, KIR
studies provide a foundation for constructing new therapeutic
interventions for alleviating a variety of diseases, including
chronic viral infections and cancer. Although coming far since
the first descriptions of KIRs in the 1990s, many questions
remain unresolved and, undoubtedly, new questions will
emerge. Exciting years and the eighth KIR workshop are still to
come. The eighth workshop will be organized by Martin Maiers,
Sarah Cooley and Jeffrey Miller in Minneapolis, USA.ACKNOWLEDGMENTS
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